Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Abingdon Health PLC ( (GB:ABDX) ) has shared an update.
Abingdon Health plc, an AIM-quoted international developer, manufacturer and regulatory services provider for rapid diagnostic tests and med-tech, focuses on contract development and manufacturing of lateral flow assays and associated regulatory and analytical services for global healthcare and life sciences customers. Founded in 2008 and headquartered in York with facilities in Doncaster and Madison, the group supports clients from concept through to commercial-scale manufacturing and regulatory approval.
The company announced it will release interim results for the six months to 31 December 2025 on 17 March 2026, accompanied by a live online investor presentation that is open to existing and potential shareholders via the Investor Meet Company platform. The planned presentation underlines Abingdon Health’s efforts to maintain active engagement with investors and may provide further clarity on trading performance and strategic progress in its diagnostics and regulatory services businesses.
The most recent analyst rating on (GB:ABDX) stock is a Hold with a £5.50 price target. To see the full list of analyst forecasts on Abingdon Health PLC stock, see the GB:ABDX Stock Forecast page.
Spark’s Take on GB:ABDX Stock
According to Spark, TipRanks’ AI Analyst, GB:ABDX is a Neutral.
Abingdon Health PLC’s overall stock score is primarily influenced by its mixed financial performance, with strong revenue growth overshadowed by profitability and cash flow challenges. The technical analysis indicates a neutral trend, lacking strong momentum. The valuation is unattractive due to a negative P/E ratio and no dividend yield. These factors collectively result in a moderate overall score.
To see Spark’s full report on GB:ABDX stock, click here.
More about Abingdon Health PLC
Abingdon Health plc is a York-based med-tech contract service provider specialising in rapid diagnostic tests and in vitro diagnostics. The group operates as a CDMO, offering lateral flow product development, regulatory support, technology transfer and manufacturing for applications including infectious disease, clinical and companion diagnostics, animal health and environmental testing.
Through its regulatory services businesses, Compliance Solutions (Life Sciences) and IVDeology, the company supports medical device and IVD clients with global market access, covering quality systems, technical documentation, audits and training. Its Abingdon Analytical unit in Doncaster provides analytical testing and performance evaluation, while additional laboratories and commercial offices are located in Madison, Wisconsin, serving an international customer base.
Average Trading Volume: 110,593
Technical Sentiment Signal: Hold
Current Market Cap: £16.95M
See more data about ABDX stock on TipRanks’ Stock Analysis page.